642 related articles for article (PubMed ID: 31384529)
1. Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application.
Xia Q; Zhang Y; Li Z; Hou X; Feng N
Acta Pharm Sin B; 2019 Jul; 9(4):675-689. PubMed ID: 31384529
[TBL] [Abstract][Full Text] [Related]
2. Carbon nanotubes for delivery of small molecule drugs.
Wong BS; Yoong SL; Jagusiak A; Panczyk T; Ho HK; Ang WH; Pastorin G
Adv Drug Deliv Rev; 2013 Dec; 65(15):1964-2015. PubMed ID: 23954402
[TBL] [Abstract][Full Text] [Related]
3. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
4. Oxygen self-enriched nanoparticles functionalized with erythrocyte membranes for long circulation and enhanced phototherapy.
Ren H; Liu J; Li Y; Wang H; Ge S; Yuan A; Hu Y; Wu J
Acta Biomater; 2017 Sep; 59():269-282. PubMed ID: 28663143
[TBL] [Abstract][Full Text] [Related]
5. Erythrocytes Nanoparticle Delivery: A Boon for Targeting Tumor.
Siddique AR; Bhagwat GS
Adv Pharm Bull; 2024 Mar; 14(1):132-146. PubMed ID: 38585450
[TBL] [Abstract][Full Text] [Related]
6. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
7. Pure drug nano-assemblies: A facile carrier-free nanoplatform for efficient cancer therapy.
Fu S; Li G; Zang W; Zhou X; Shi K; Zhai Y
Acta Pharm Sin B; 2022 Jan; 12(1):92-106. PubMed ID: 35127374
[TBL] [Abstract][Full Text] [Related]
8. Small interfering RNA for cancer treatment: overcoming hurdles in delivery.
Charbe NB; Amnerkar ND; Ramesh B; Tambuwala MM; Bakshi HA; Aljabali AAA; Khadse SC; Satheeshkumar R; Satija S; Metha M; Chellappan DK; Shrivastava G; Gupta G; Negi P; Dua K; Zacconi FC
Acta Pharm Sin B; 2020 Nov; 10(11):2075-2109. PubMed ID: 33304780
[TBL] [Abstract][Full Text] [Related]
9. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.
Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X
Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200
[TBL] [Abstract][Full Text] [Related]
10. Enhanced photothermal therapy of biomimetic polypyrrole nanoparticles through improving blood flow perfusion.
Wang X; Li H; Liu X; Tian Y; Guo H; Jiang T; Luo Z; Jin K; Kuai X; Liu Y; Pang Z; Yang W; Shen S
Biomaterials; 2017 Oct; 143():130-141. PubMed ID: 28800434
[TBL] [Abstract][Full Text] [Related]
11. Erythrocyte membrane is an alternative coating to polyethylene glycol for prolonging the circulation lifetime of gold nanocages for photothermal therapy.
Piao JG; Wang L; Gao F; You YZ; Xiong Y; Yang L
ACS Nano; 2014 Oct; 8(10):10414-25. PubMed ID: 25286086
[TBL] [Abstract][Full Text] [Related]
12. Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment.
Zhang M; Hu W; Cai C; Wu Y; Li J; Dong S
Mater Today Bio; 2022 Mar; 14():100223. PubMed ID: 35243298
[TBL] [Abstract][Full Text] [Related]
13. Erythrocyte-biomimetic nanosystems to improve antitumor effects of paclitaxel on epithelial cancers.
Song M; Dong S; An X; Zhang W; Shen N; Li Y; Guo C; Liu C; Li X; Chen S
J Control Release; 2022 May; 345():744-754. PubMed ID: 35381274
[TBL] [Abstract][Full Text] [Related]
14. Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment.
Li R; He Y; Zhang S; Qin J; Wang J
Acta Pharm Sin B; 2018 Jan; 8(1):14-22. PubMed ID: 29872619
[TBL] [Abstract][Full Text] [Related]
15. Red Blood Cell Membrane Camouflaged Mesoporous Silica Nanorods as Nanocarriers for Synergistic Chemo-Photothermal Therapy.
Zong S; Cao C; Chen K; Cui Y; Li J; Wang Z
IEEE Trans Nanobioscience; 2023 Jul; 22(3):655-663. PubMed ID: 37015652
[TBL] [Abstract][Full Text] [Related]
16. Photosensitizer-loaded cell membrane biomimetic nanoparticles for enhanced tumor synergetic targeted therapy.
Zhang Y; Ma N; Luo C; Zhu J; Bao C
RSC Adv; 2020 Mar; 10(16):9378-9386. PubMed ID: 35497215
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cell delivery and cell membrane camouflaged PLGA nanoparticles in the delivery of shikonin for colorectal cancer treatment.
Zhou J; Jiang Z; Sun R; Pan D; Du Q; Zhou X; Chen Y; Chen Y; Peng J
Colloids Surf B Biointerfaces; 2024 Jun; 241():114017. PubMed ID: 38865869
[TBL] [Abstract][Full Text] [Related]
18. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
Yang M; Li J; Gu P; Fan X
Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
[TBL] [Abstract][Full Text] [Related]
19. Red blood cell membrane-coated upconversion nanoparticles for pretargeted multimodality imaging of triple-negative breast cancer.
Li M; Fang H; Liu Q; Gai Y; Yuan L; Wang S; Li H; Hou Y; Gao M; Lan X
Biomater Sci; 2020 Mar; 8(7):1802-1814. PubMed ID: 32163070
[TBL] [Abstract][Full Text] [Related]
20. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
